Centre asks states, UTs to extend hole between two doses of Covishield | India Information
New Delhi: The Centre on Monday (March 22) has requested states and Union Territories to extend the hole between two doses of Serum Institute of India’s (SII) ‘Covishield’ from 4-6 weeks to 4-8 weeks now.
“In view of the rising scientific proof, the interval between two doses of a selected COVID 19 vaccine i.e. COVISHIELD, has been revisited by Nationwide Technical Advisory Group on Immunization (NTAGI) and subsequently by Nationwide Professional Group on Vaccine Administration for COVID-19 (NEGVAC) in its twentieth assembly. Throughout this assembly, the advice has been revised to offer 2nd dose of COVISHIELD at 4-8 weeks’ interval after the first dose, as an alternative of earlier practiced interval of 4-6 weeks,” the federal government stated.
The Centre additionally clarified that the above instruction is just for Covishield and never Bharat Biotech’s Covaxin. “This choice of revised time interval between two doses is relevant ONLY to COVISHIELD and NOT to COVAXIN Vaccine,” the federal government’s press launch said.
The federal government said that, as per scientific knowledge, safety is enhanced if the second dose of Covishield is run between 6-8 weeks, however not later than the stipulated interval of 8 weeks.